spacer
home > ict > winter 2019 > the evolution of environmental monitoring
PUBLICATIONS
International Clinical Trials

The Evolution of Environmental Monitoring

Clinical trials are a complex undertaking and a huge investment for the sponsor, taking a significant amount of time to complete and to produce a marketable drug. Added complexity comes from the inherently global nature of recent clinical trials which are spreading operations over multiple nations, sites, and premises. Ensuring sufficient enrolment numbers and monitoring activities on multiple sites and suchlike justifiably take up a major portion of sponsor and investigator focus.

A Complicated Process

With the vast amount of analytical activities in a clinical study, it is easy to forget that even in national – and more so, in international studies – logistics complexity is a major concern. However, while logistics is a support function for the overall trial operation, it also needs planning to function efficiently.

In a drug trial, ensuring that the investigational medicinal products (IMPs) reach the site in good condition and that samples travel from collection points to laboratories in correct environments is paramount. With lab specialisation requiring long transportation distances and the parallel supply chains of international, regional, and local hubs often working without visibility to each other, guaranteeing the integrity of the supply is not always easy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Jukkapekka ‘JP’ Asikainen is the founder and CEO at Sensire. He is a leading expert on the cold supply chain and an accomplished innovator of marketleading wireless monitoring solutions for pharma logistics, healthcare services, and processing and manufacturing operations. JP is a highly successful serial entrepreneur and has over 30 years’ experience in executive management, marketing and sales. As a longtime specialist on environmental monitoring systems, JP is exceedingly experienced at providing customers with real-life solutions to real-world challenges.

Ossi Laakkonen is Technical Director at Sensire. He is an expert in cold supply chain technology design and accomplished in designing robust and comprehensive environmental monitoring systems for a wide variety of applications. Ossi’s speciality is in the field of IoT and he has over 10 years of experience with working on wireless sensor network research and development. He also holds several groundbreaking patents on these technologies.
spacer
Jukkapekka ‘JP’ Asikainen
spacer
spacer
spacer
Ossi Laakkonen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation

At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement